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Assessment of Vascular and Cellular Integrity in
Reoerfused lnfercted Mvocsrdium Ueirm–,.
Gadolinium-enhanced tiR Imaging -
J. Schwitter, M.Saeed, M.F. Wendland, E. Canet, N. Derugin, C.B. Higgins,
Universifyof California San Francisco, San Frsnciaco, CA, USA
Myocardial concentration of an MR contrast medium (CM) following iv ad-
ministration depends on convective (macromolecules) and diffusive (macro-
molecules) transport of the CM within the interatitium, and the CM’s ability to
enter oellularspace (cellular integrity). As vascular injury results in ademafor-
mation and increase in interstitial pressure it may affect convective transport.
We hypothesized that 1) convective penetration of a macromolecular CM
causes hypoenhancement of the injury core, whereas diffusive penetration
of a macromolecularCfvfcauses homogeneous enhancement, 2) signal in-
tensity (S1)of the macromolecular-enhancedinjury zone is related to the loss
of cellularintegr”Ry.Tovary the severily of injury,72 ratewere subjected to20,
30,45, and 75 min (n= 18, resp.) of left anterior descending coronaty artety
reclusion and 2 hours reperfusion followed by injection of 0.05 mmol/kg of
the macromolecular Gd-diethylene-triaminepantaacatic (GdDTPA)-albumin,
of the macromolecularGdDTPA-bismethylamide (GdDTPA-BMA),or saline (n
= 24, resp.). 3 min after Injection the rats were killed and the excised hearts
imaged (TI-weighted spin echo: TWTE = 300/8 ms, 2T system), followed
by triphenyltetrazolium chloride (TTC) staining for infarct detection. Size of
Injury (enhanced zone and dark core on MR images, infarct on TTC) was
expressed as % slice surface. ITC and MR infarct size correlated well (r
= 0.96, both CM). On GdDTPA-albumin enhanced images the bounda~ of
the injury zone was enhanced. The extent of the hypointense core increased
with occlusion time (p c 0.03, ANOVA). On GdDTPA-BMA enhanced images
the injury zone was homogeneously enhanced. SI increased with occlusion
time (p <0.02, ANOVA).
Conclusion: Different enhancement patterns of micro- and macromolecu-
lar MR CM in reparfused myocardium are related to the severity of vascular
and oellulardamage. We speculate that high tissue preaeureprevents macro-
molecular CM to distribute in the injury core.
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1800+1Non~nvasive31p~Pe~t~o*oP~~**@~mentof
Regional Myocardial Meteboliem Post-Infarction
G.Wisenberg, C.M. Campbell, R.T.Thompaon, J. Sykes. Univeraifyof
Western Ontario, London, Ontario, Canada
At 2 Tes]a non.invasive 31p MR spectroscopy has limited spatial resolution
(voxel siz~ 12 cm3). We wished to determine if beneficial effects of anti-
ischemic therapy could be demonstrated, and the time course of theee
changes monitored in a canine anterior infarct model, in 5 groups: l-Controls
(n-lO), 11-Nitroglycerin(n = 11), 111-Propranolol(n = 10), IV-Diltiezem (n =
11), V-Superoxide dismutase [SOD] (n = 9), at baseline, during 2 hours
of occlusion, immediately following reperfusion, and at 1 and 3 weeks. The
results for PH in the infarct zone and infarct size are presented in the following
table.
CNTRL NTG PROP DILT SOD
Saseline 7.03+ 0.09 7.16+0.23 6.90+0.43 7.05+ 0.43 7.03 zk0.32
Occ 1 6.18 + 0.29 6.78+0.34 6.60+0.16 6.63+ 0.26 6.61 *0.44
DCC2 6.16 + 0.28 6.44 +0.37 6.34+0.36 6.41 + 0,42 6.28* 0,51
Reperfusion 6.51 + 0.33 6.50+0.44 6.29* 0.84 6.69+ 0S8 6.30+0.31
1 week 6.55 + 0.36 6.96 +0.42 7.01 + 0.41 7.05+ 0.17 7.38*0.24
3 weeka 7.09 + 0.58 7.26 +0.44 6.60* 0.56 6.91 + 0.46 7.20+ 0.38
lnfsrcVRlskZone 1.03 + 0.39 0.52 +0.50 0.71& 0.66 0.96+ 0.06 0.64+ 0.40
All treatments produced an attenuation in the fall in pH vs controls (p
< 0.05) while only NTG and SOD effected a significant reduction in infarct
size. Metabolic stunning was present out to 1 week in controls but treatment
expedited the recovery.
The ability to monitor theae effects completely non-invasively and track
them sequentially indicates spectroscopy’s suitability for clinical evaluation
and monitoring of interventional therapy.
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Function of the Adenoeine Sensitive Coronary
—
ReSiSfSnCSin Patienta with Mild Dilated
Cardiomyopathy
D. Neglia, M. Gallopin, A. Giorgefti, G. Sambuceti, J. Schneider-Eicke,
P.Salvadori, i. Simonetti, A. L’Abbate, O. Parodi. CNR Institute of C/inioa/
Physiology, Pisa, Italy Lstitutodi Clinica Medica Genera/e e Cardiologia,
Florence, /ta/y
Depressed myocardial blood flow after dipyridamole (DIP) was demonstrated
in mild dilated cardiomyopathy. Whether this is due to a lower rate of en-
dogenous adenosine (ADO) accumulation in the myocardium after DIP,,an
abnormal coronary vasodilating response to ADD or an additional coronaty
resietence (CR) other than that responsive to ADO, is not yet clarified. To
this purpose, absolute MBF (ml*min-l*g-1) and total CR (from mean arterial
pressure and MBF, mmHg/ml*min-l*g-1) were assessed by 13N-ammonia
and positron emission tomography in 34 pta with mild DCM (27 men; age 49
+ 10yrs; NYHA class 1–II;LVejection fraction 0.37+ 0.08) and in 15 normals
(6 men; age 49 + 7 yrs). The etudy was performed at rest and after iv. DIP
(0.56 mg/Kg in 4’) in all subjects and also during iv. ADO (140 #@Kg for6’) in
IOpts. Theexfent of coronatyvasodilation during DIPor ADO was expressed
by the absolute reduction in CR (rest CR – stress CR). In pts, compared with
normals, mean MBF was depressed at reat (0.73 + 0.23 vs 1.04 + 0.22, P
< 0.01) and after DIP (1.79 & 0.76 vs 3.67 + 0.86, P < 0.01) and mean CR
was increased at rest (140 +40 vs 94 + 24, P < 0.01) and after DIP (61 +
25 vs 25 + 7, P < 0,01). However, the reduction in CR was similar in pts and
normals (78 + 29 vs 68 + 22, ns). Mean MBF, mean CR and CR reduction
during ADO were not different from DIP (1.40 + 0.72 vs 1.67 + 0.87; 61 +
36 vs 84 + 21; 72&40 vs 89 + 28, respectively; ns). In conclusion, in mild
DCM: 1) MBF is similarly depressed after DIP and during ADO, excluding an
abnormality of ADO accumulation in the myocardium; 2) the drop in CR after
DIP is similar to that in normals, suggesting a preserved ADO dependent
vasodilation; 3) the sustained increase in CR at rest and during stress etands
for an abnormal additional resistance etill to be characterized.
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Incidence and Clinical Outcome of Abrupt Vessel
Closure Among Patients Receiving Abciximab
Durirw High-Risk Percutsneoue Coronaw
lnterv;nti&t: EPfC Trial Results -
F.V.Aguirre, E.J. Topol, J. Leimberger, N. Kleiman, A.M. Lincoff,
T.J. Donohue, R.M. Califf. St. Louis Univeraify Hea/th Sciences CenteL St.
Louis, MO, USA
To assess the impact of Abciximab on the incidence and clinical conse-
quences of abrupt vessel closure (AVC), we examined 1,984/2,099 (95%)
patients undergoing high-risk percutaneous coronary intervention in the EPIC
trial, Patients received procedural aspirin (325 mg) and high-dose heperin
followed by a 12-hr infusion of IV heparin. AVC occurred in 182/1994 (9.1%)
patients. AVCwas slightly lower in abciximab- (116/1333! 8.7%) as compared
to placebo-treated (66/661; 10.0%) patients (p = 0.35).
ClinicalCJUtCOIIWBetween Treatment Groupa
Placsbo Abciximab II vslue
(n=66) (n= 116)
in-HosDital(4A) Daeth 5 5 NS
Ml 36 21 0.023
Urgent re-PTCA 14 3 0,0093
UrgentCABG 18 11 0.019
30-day (ok) Death 3 5 NS
Ml 35 21 0.038
Uraent re-PTCA 15 3 0,0025
M~or bleeding 20 27 0.282
In conclusion: 1) In EPIC, AVC during coronary intewention was se-
sociated with high rates of adverse past-procedural clinical outcomes. 2)
Abciximab significantly reduced the morbidity of AVC during high-riak ooro-
nary intervention, resu~ing in lower in-hospital and 3U-day rates of Ml and
repeat PTCAwithoutcontributing to excess procedure-related major bleeding
complications.
